Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, and University Medical Center, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, and University Medical Center, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands; The Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Cell Stem Cell. 2020 Nov 5;27(5):705-731. doi: 10.1016/j.stem.2020.10.014.
CRISPR-Cas technology has revolutionized biological research and holds great therapeutic potential. Here, we review CRISPR-Cas systems and their latest developments with an emphasis on application to human cells. We also discuss how different CRISPR-based strategies can be used to accomplish a particular genome engineering goal. We then review how different CRISPR tools have been used in genome engineering of human stem cells in vitro, covering both the pluripotent (iPSC/ESC) and somatic adult stem cell fields and, in particular, 3D organoid cultures. Finally, we discuss the progress and challenges associated with CRISPR-based genome editing of human stem cells for therapeutic use.
CRISPR-Cas 技术已经彻底改变了生物学研究,并具有巨大的治疗潜力。在这里,我们回顾了 CRISPR-Cas 系统及其最新进展,重点介绍了其在人类细胞中的应用。我们还讨论了如何使用不同的基于 CRISPR 的策略来实现特定的基因组工程目标。然后,我们回顾了不同的 CRISPR 工具在人类干细胞的基因组工程中的应用,涵盖了多能(iPSC/ESC)和成体干细胞领域,特别是 3D 类器官培养。最后,我们讨论了基于 CRISPR 的基因组编辑用于人类干细胞治疗的相关进展和挑战。